Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

1.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

9.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.7K
Introduction to Hemostasis01:05

Introduction to Hemostasis

9.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.4K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

7.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.1K
Vascular Spasm01:16

Vascular Spasm

2.1K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
2.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

968
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
968

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-operative oxygen delivery and delirium after cardiac surgery with cardiopulmonary bypass: A multisite retrospective cohort study of 1,690 patients.

Perfusion·2026
Same author

Discharge prescription patterns in multiarterial versus single-arterial coronary artery bypass grafting: A regional multicenter cohort analysis.

JTCVS open·2025
Same author

HybridoNet-Adapt: A domain-adapted framework for accurate lithium-ion battery RUL prediction.

PloS one·2025
Same author

Systemic Anticoagulation at Discharge in Cardiac Surgical Patients With Postoperative Atrial Fibrillation: A Statewide Cohort Study.

Annals of thoracic surgery short reports·2025
Same author

The 7 Pillars of Preoperative Anemia Management.

Innovations (Philadelphia, Pa.)·2025
Same author

State-of-the-Art Review: Operating Room Extubation.

Innovations (Philadelphia, Pa.)·2025
Same journal

AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte.

The heart surgery forum·2024
Same journal

Cerebral Embolism and MINOCA Secondary to Left Atrial Myxoma after Occlusion of Atrial Septal Defect by Amplatzer Occluder: A Case Report.

The heart surgery forum·2024
Same journal

Working Around: The Use of AngioVac and Micra Transcatheter Leadless Pacemaker Implantation in a Critically Ill Patient Receiving Extracorporeal Membrane Oxygenation.

The heart surgery forum·2024
Same journal

Effects of Concomitant CABG on Outcomes in Veterans Who Require Surgery for Endocarditis.

The heart surgery forum·2024
Same journal

Effects of Short-Term Episodes of Atrial Fibrillation after Coronary Artery Bypass Grafting on the Long-term Incidence of Atrial Fibrillation and Ischemic Stroke.

The heart surgery forum·2024
Same journal

A Meta-Analysis for Postoperative Alternations of Aortic Coarctation.

The heart surgery forum·2024
See all related articles

Related Experiment Video

Updated: Oct 1, 2025

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

408

All Bleeding Stops, Eventually (But: The Sooner The Better!).

Curt Tribble1, Lam Pham1, Nicholas Teman1

  • 1Division of Cardiac Surgery, University of Virginia, Charlottesville, VA, USA. ctribble@virginia.edu.

The Heart Surgery Forum
|March 3, 2022
PubMed
Summary
This summary is machine-generated.

Managing post-cardiac surgery oozing requires vigilance. This guide addresses non-surgical bleeding and the risk of cardiac tamponade in the intensive care unit (ICU).

More Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.6K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Related Experiment Videos

Last Updated: Oct 1, 2025

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
08:27

A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine

Published on: December 6, 2024

408
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.6K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.0K

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Intensive Care Medicine

Background:

  • Post-cardiac surgery patients admitted to the ICU may present with significant oozing.
  • Identifying the source of bleeding is critical for appropriate management.
  • Non-surgical bleeding requires distinct management strategies compared to surgical bleeding.

Purpose of the Study:

  • To outline the initial management of a cardiac surgery patient with non-surgical oozing in the ICU.
  • To emphasize the importance of monitoring for tamponade physiology.
  • To provide a framework for surgical residents managing complex post-operative cases.

Main Methods:

  • Clinical assessment of oozing post-cardiac surgery.
  • Differential diagnosis of non-surgical bleeding causes.
  • Monitoring for signs and symptoms of cardiac tamponade.
  • Review of established intensive care unit (ICU) protocols for post-operative bleeding.

Main Results:

  • Non-surgical oozing can be challenging to manage and requires a systematic approach.
  • Early recognition of tamponade physiology is crucial for preventing adverse outcomes.
  • Multidisciplinary collaboration is essential for optimal patient care.

Conclusions:

  • Effective management of post-cardiac surgery oozing hinges on accurate diagnosis and timely intervention.
  • Vigilance for tamponade physiology is paramount in the ICU setting.
  • Surgical residents must be prepared to manage complex post-operative complications.